BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9166837)

  • 1. Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.
    Prosper F; Vanoverbeke K; Stroncek D; Verfaillie CM
    Blood; 1997 Jun; 89(11):3991-7. PubMed ID: 9166837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
    Gupta P; McCarthy JB; Verfaillie CM
    Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
    Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
    Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
    Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R
    Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor.
    Hogge DE; Lansdorp PM; Reid D; Gerhard B; Eaves CJ
    Blood; 1996 Nov; 88(10):3765-73. PubMed ID: 8916940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: a comparison with steady-state bone marrow and peripheral blood.
    Benboubker L; Binet C; Cartron G; Bernard MC; Clement N; Delain M; Degenne M; Desbois I; Colombat P; Domenech J
    Exp Hematol; 2002 Jan; 30(1):74-81. PubMed ID: 11823040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
    Verfaillie CM
    Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
    Fruehauf S; Haas R; Conradt C; Murea S; Witt B; Möhle R; Hunstein W
    Blood; 1995 May; 85(9):2619-26. PubMed ID: 7537123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
    Herman P; Ferrant A; De Bruyère M; Straetmans N
    Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
    Koller MR; Palsson MA; Manchel I; Palsson BO
    Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusible factors from the murine cell line M2-10B4 support human in vitro hematopoiesis.
    Burroughs J; Gupta P; Blazar BR; Verfaillie CM
    Exp Hematol; 1994 Oct; 22(11):1095-101. PubMed ID: 7523163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood.
    Roecklein BA; Reems J; Rowley S; Torok-Storb B
    Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
    Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.